RecruitingNot ApplicableNCT05640089

FMRI-neurofeedback in Depression

A Randomised Controlled Trial of FMRI-neurofeedback in Depression


Sponsor

Maastricht University Medical Center

Enrollment

120 participants

Start Date

Jan 25, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Previous studies with fMRI-neurofeedback in depression have demonstrated a good safety profile and considerable symptom reduction. The goal of this clinical trial is to compare fMRI-neurofeedback plus standard care with standard care in patients with depression. Participants will either receive standard care, or standard care plus a fMRI neurofeedback training, consisting of 5 neurofeedback training sessions. Symptom severity will be assessed before, immediately after and 6 months after the intervention.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a brain training technique called fMRI neurofeedback — where you learn to control your own brain activity using real-time brain scan feedback — can help reduce depression symptoms in people who haven't fully responded to antidepressants. **You may be eligible if...** - You have been diagnosed with a depressive disorder - You have been on a stable antidepressant medication for at least 4 weeks - You currently have moderate to severe depression (based on a symptom questionnaire score) **You may NOT be eligible if...** - You have a metal implant or pacemaker that makes MRI scans unsafe - You have a history of bipolar disorder, psychosis, or psychotic depression - You have used illegal drugs in the past 4 weeks - You drink alcohol excessively in a way that affects daily life - You have a neurological disease that could affect brain scan results (e.g., history of stroke) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERfMRI-based neurofeedback

Participants use fMRI-based neurofeedback to train the upregulation of brain areas that respond to positive affective pictures (as identified during a functional localiser scan).


Locations(3)

Mondriaan Zorggroep

Maastricht, Netherlands

Maastricht University

Maastricht, Netherlands

Maastricht UMC+

Maastricht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05640089


Related Trials